Catalyst Wire Dossier Catalyst Wire Dossier

vaniprevir

vaniprevir · Merck Sharp & Dohme LLC
Drug timelines are a Plus or Pro feature.

10 regulatory and trial events tracked for vaniprevir, covering 2014-09-29 to 2014-10-13. Get the full timeline:

Most recent: Clinical Trial Update: Study of Vaniprevir Plus PegIntron®/Ribavirin in Japanese Participants With Chronic Hepatitis C Who Relapsed After Treatment (MK-7009-044) [Phase 3]

See pricing